[go: up one dir, main page]

TN2013000137A1 - Pharmaceutical compositions containing a dgat 1 inhibitor - Google Patents

Pharmaceutical compositions containing a dgat 1 inhibitor

Info

Publication number
TN2013000137A1
TN2013000137A1 TNP2013000137A TN2013000137A TN2013000137A1 TN 2013000137 A1 TN2013000137 A1 TN 2013000137A1 TN P2013000137 A TNP2013000137 A TN P2013000137A TN 2013000137 A TN2013000137 A TN 2013000137A TN 2013000137 A1 TN2013000137 A1 TN 2013000137A1
Authority
TN
Tunisia
Prior art keywords
dgat
inhibitor
pharmaceutical compositions
compositions containing
properties
Prior art date
Application number
TNP2013000137A
Other languages
French (fr)
Inventor
Hong Wen
Natrajan Kumaraperumal
Richard Nause
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/056275 external-priority patent/WO2012051488A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2013000137A1 publication Critical patent/TN2013000137A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a pharmaceutical composition comprising a) a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, b) one or more, e.g. 1, 2 or 3, surfactants with lubricant properties; c) one or more, e.g. 1, 2 or 3, dry binders with disintegrant properties; d) one or more, e.g. 1, 2 or 3, fillers, and e) one or more, e.g. 1, 2 or 3, disintegrants.
TNP2013000137A 2011-10-14 2013-03-28 Pharmaceutical compositions containing a dgat 1 inhibitor TN2013000137A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/056275 WO2012051488A1 (en) 2010-10-14 2011-10-14 Pharmaceutical compositions containing a dgat1 inhibitor

Publications (1)

Publication Number Publication Date
TN2013000137A1 true TN2013000137A1 (en) 2014-06-25

Family

ID=54360805

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000137A TN2013000137A1 (en) 2011-10-14 2013-03-28 Pharmaceutical compositions containing a dgat 1 inhibitor

Country Status (1)

Country Link
TN (1) TN2013000137A1 (en)

Similar Documents

Publication Publication Date Title
PH12013500695A1 (en) Pharmaceutical compositions containing a dgat1 inhibitor
MX2018001990A (en) Compositions comprising a pi3k inhibitor and an hdac inhibitor.
TN2016000081A1 (en) Aminoheteroaryl benzamides as kinase inhibitors
GEP20146102B (en) Compounds and compositions as protein kinase inhibitors
TN2015000121A1 (en) Gdf-8 inhibitors
MX2013007336A (en) Bi-heteroaryl compounds as vps34 inhibitors.
TN2009000049A1 (en) A pyrrolopyrazin as syk-kinase inhibitor
GEP20146125B (en) Aminopyrimidines as syk inhibitors
MY172924A (en) Neprilysin inhibitors
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
IN2012DN01233A (en)
MY170935A (en) Neprilysin inhibitors
MX2013006802A (en) Neprilysin inhibitors.
MY187718A (en) Pharmaceutical formulations
MX361618B (en) Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same.
IN2014CN04530A (en)
IN2014CN03803A (en)
MY151295A (en) Pyrimidyl indoline compound
MY151003A (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
PH12015502802A1 (en) Formulation comprising a hypolipidemic agent
IN2012DN02502A (en)
TN2012000105A1 (en) Spirolactam derivatives and uses of same
MX2009008028A (en) Benzofuran antiparasitic agents.
PH12012500992A1 (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use